NKMax America Presents Promising Clinical Research Findings at 2020 ASCO Virtual Conference

SANTA ANA, Calif., May 29, 2020 (GLOBE NEWSWIRE) — NKMax America, a biotechnology company harnessing the power of the body’s immune system through the development of Natural Killer (NK) cell therapies, announced the publication of three abstracts in the ASCO Meeting Library — available in the Journal of Clinical Oncology and a poster presentation of one of the abstracts.